LifeMD, Inc. - Common Stock (LFMD)
4.9500
+0.0900 (1.85%)
Lifemd Inc is a biotechnology company focused on advancing personalized medicine by leveraging cutting-edge technology and data analytics to develop innovative diagnostic solutions and therapeutics
Their mission centers around improving patient outcomes through tailored healthcare approaches, harnessing the power of genetic information and biomarkers to better understand individual health traits and disease predispositions. By aiming to provide precise treatment options, Lifemd Inc is dedicated to transforming the landscape of healthcare and empowering patients with actionable insights for managing their health.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · February 21, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · February 21, 2025

Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.
Via InvestorPlace · July 16, 2024

Via Benzinga · June 10, 2024

Via Benzinga · January 19, 2024

Via Benzinga · May 9, 2024

Via Benzinga · January 18, 2024

Via Benzinga · May 9, 2024

LFMD stock results show that LifeMD beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024

On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Via Investor's Business Daily · April 30, 2024

Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday.
Via Investor's Business Daily · April 30, 2024

On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Via Investor's Business Daily · April 25, 2024

Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.
Via Investor's Business Daily · March 26, 2024

The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Via Investor's Business Daily · March 19, 2024

In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.
Via Investor's Business Daily · March 18, 2024

With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around.
Via InvestorPlace · March 14, 2024

Via Benzinga · March 11, 2024

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQBLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
Via Benzinga · March 11, 2024

These three companies are beaten up stocks to buy, as their oversold status and solid fundamentals make them attractive picks.
Via InvestorPlace · March 7, 2024

Shares of Mobileye Global Inc. (NASDAQMBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via Benzinga · January 4, 2024

Via Benzinga · January 4, 2024

The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading
Via InvestorPlace · December 22, 2023